Barclays CEO CS Venkatakrishnan to undergo cancer treatment but will 'continue to be actively engaged'
The Indian-born banker said in a letter that his condition was curable and that the doctors lauded his prognosis, with the treatment in New York expected to last between 12 and 16 weeks.
British bank Barclays on Monday (28) said that its chief executive officer CS Venkatakrishnan would be undergoing treatment for non-Hodgkin lymphoma, a type of cancer, and that would mean it would work from home for some time.
According to a Reuters report, Venkatakrishnan, who was born in India, said in a letter that his condition was curable and that the doctors lauded his prognosis, with the treatment in New York expected to last between 12 and 16 weeks, Reuters reported.
“During this period, the company will run normally, and I will continue to be actively engaged in managing it,” Venkatakrishnan, who is known in the bank as Venkat, said in the letter.
A spokesperson for the bank said Barclays had not appointed any interim chief executive and that Venkat and the lender’s executive committee were expected to continue running it, the report added.
Non-Hodgkin lymphoma is a cancer that develops in the lymphatic system and weakens the immune system, but most cases are considered “very treatable”, according to the website of Britain’s National Health Service.
Vankatakrishnan, who is an American citizen, might have to reduce his public engagements, such as appearance at the World Economic Forum meetings in Davos, Switzerland, in January, according to a spokesperson from Barclays, the Reuters report added.
A former banker at JPMorgan, Venkatakrishnan saw off a difficult first year in charge of the British bank since taking over from Jes Staley in November 2021.
Barclays’ strong investment banking results in the middle of volatile markets were overshadowed by an administrative error that saw it sell more securities in the US than permitted, leading to penalties and losses.
Venkatakrishnan, who oversaw risk at the bank before taking over, called the error “preventable” and sought to reassure investors that investments in better controls mean a repeat will be avoided.
Last month, the bank beat analysts’ expectations with a small rise in third quarter profit, but still faces a tough economic outlook in the domestic market as the British economy faces tough challenges.
THE BAPS Hindu Mandir in Abu Dhabi has won the MONDO-DR Award 2025 in the “House of Worship” category, one of the top honours in the global audiovisual industry.
The awards, known as the “Oscars of the AV world”, were held at Ole Red Orlando in Florida, US.
The Mandir’s “The Fairy Tale” immersive show was selected from entries by cathedrals, mosques and synagogues worldwide for its audiovisual design and integration.
The awards are judged by an international panel and published by MONDO-DR, a magazine on technology in entertainment and architecture.
Adrian Goulder, Technical Director at VueAV, said, “What makes ‘The Fairy Tale’ immersive show at the BAPS Hindu Mandir stand apart, and so impactful, is its creativity, concept and global message.”
Swami Brahmaviharidas, Head of the BAPS Hindu Mandir, said, “We’re honoured and humbled to receive this award. This was never about just installing a show, sound systems or lighting. This was about designing an environment where every heart, regardless of background, can feel a deeper connection to universal spirituality.”
The Mandir, the first traditional Hindu stone temple in the Middle East, has earlier received the MEED Project Award (2024) for “Best Cultural Project” in the UAE and MENA region.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.